baymed venture partners
VC Fund
San Francisco, United States
baymed venture partners is a VC fund in San Francisco focused on Health Care and Medical. Baymed Venture Partners invests in early-stage medical and digital health companies
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries baymed venture partners invests in
Stages baymed venture partners invests in
Countries baymed venture partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Gary Gershony
|
|||
Neil Meyer
|
|||
Investment Focus
Industry
- Health Care 2 (67%)
- Medical 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series C 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gary Gershony
Founder and General Partner
|
Founder and General Partner | Total investments: 1 | Find email | |
|
Neil Meyer
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AtaCor Medical
|
AtaCor Medical Inc., is a San Clemente-based medical device maker. It designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. | $28M / Series C / Apr 24, 2024 | |
Deep Blue Medical Advances
|
Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Their surgeon-invented mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional meshfixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, Their Anchor Clip fixation device design enables faster, stronger, easier mesh implantation. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure. | $7M / Series A / Jun 28, 2022 | |
|
Deep Blue Medical Advances
|
Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Their surgeon-invented mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional meshfixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, Their Anchor Clip fixation device design enables faster, stronger, easier mesh implantation. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure. | $7M / Series A / Jun 28, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does baymed venture partners invest in?
baymed venture partners invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact baymed venture partners?
Public channels for baymed venture partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at baymed venture partners?
The team at baymed venture partners includes Gary Gershony (Founder and General Partner) and Neil Meyer (Co-Founder and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
